Table 3.

Signs and symptoms leading to the commencement of regular prophylactic therapy

SymptomPatients affected, %Patients whose symptoms resolved with therapy, %
Abdominal pain 9 (n = 4) 100 
Headaches and migraines 23 (n = 11) 82 (n = 9) 
Lethargy 19 (n = 9) 89 (n = 8) 
Persistent thrombocytopenia 23 (n = 11) 91 (n = 10) 
Recurrent MAHA episodes 4 (n = 2) 100 
Stroke and TIAs 11 (n = 5) 80 (n = 4) 
SymptomPatients affected, %Patients whose symptoms resolved with therapy, %
Abdominal pain 9 (n = 4) 100 
Headaches and migraines 23 (n = 11) 82 (n = 9) 
Lethargy 19 (n = 9) 89 (n = 8) 
Persistent thrombocytopenia 23 (n = 11) 91 (n = 10) 
Recurrent MAHA episodes 4 (n = 2) 100 
Stroke and TIAs 11 (n = 5) 80 (n = 4) 
Close Modal

or Create an Account

Close Modal
Close Modal